110 related articles for article (PubMed ID: 8570024)
1. Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord.
Teoh H; Fowler LJ; Bowery NG
Neuropharmacology; 1995 Oct; 34(10):1273-8. PubMed ID: 8570024
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.
Leach MJ; Marden CM; Miller AA
Epilepsia; 1986; 27(5):490-7. PubMed ID: 3757936
[TBL] [Abstract][Full Text] [Related]
3. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters.
Waldmeier PC; Baumann PA; Wicki P; Feldtrauer JJ; Stierlin C; Schmutz M
Neurology; 1995 Oct; 45(10):1907-13. PubMed ID: 7477991
[TBL] [Abstract][Full Text] [Related]
4. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum.
Waldmeier PC; Martin P; Stöcklin K; Portet C; Schmutz M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):164-72. PubMed ID: 8857593
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats.
Ahmad S; Fowler LJ; Whitton PS
Brain Res; 2004 Dec; 1029(1):41-7. PubMed ID: 15533314
[TBL] [Abstract][Full Text] [Related]
6. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms.
Smith CG; Bowery NG; Whitehead KJ
Neuropharmacology; 2007 Dec; 53(8):975-81. PubMed ID: 17981306
[TBL] [Abstract][Full Text] [Related]
7. Distinct electrophysiological effects of two spinally administered membrane stabilising drugs, bupivacaine and lamotrigine.
Chapman V; Wildman MA; Dickenson AH
Pain; 1997 Jul; 71(3):285-95. PubMed ID: 9231872
[TBL] [Abstract][Full Text] [Related]
8. GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists.
Teoh H; Malcangio M; Bowery NG
Br J Pharmacol; 1996 Jul; 118(5):1153-60. PubMed ID: 8818338
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.
Ahmad S; Fowler LJ; Whitton PS
Epilepsy Res; 2005 Feb; 63(2-3):141-9. PubMed ID: 15777732
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV).
Attwell PJ; Singh Kent N; Jane DE; Croucher MJ; Bradford HF
Brain Res; 1998 Sep; 805(1-2):138-43. PubMed ID: 9733953
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus.
Lee CY; Fu WM; Chen CC; Su MJ; Liou HH
Epilepsia; 2008 May; 49(5):888-97. PubMed ID: 18248444
[TBL] [Abstract][Full Text] [Related]
12. The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro.
Cunningham MO; Jones RS
Neuropharmacology; 2000 Aug; 39(11):2139-46. PubMed ID: 10963757
[TBL] [Abstract][Full Text] [Related]
13. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices.
Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M
Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders.
Braga MF; Aroniadou-Anderjaska V; Post RM; Li H
Neuropharmacology; 2002 Mar; 42(4):522-9. PubMed ID: 11955522
[TBL] [Abstract][Full Text] [Related]
15. Evidence for release of glutamic acid, aspartic acid and substance P but not gamma-aminobutyric acid from primary afferent fibres in rat spinal cord.
Teoh H; Malcangio M; Fowler LJ; Bowery NG
Eur J Pharmacol; 1996 Apr; 302(1-3):27-36. PubMed ID: 8790988
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats.
Ahmad S; Fowler LJ; Whitton PS
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):1-8. PubMed ID: 15660242
[TBL] [Abstract][Full Text] [Related]
17. Lamina-specific effects of morphine and naloxone in dorsal horn of rat spinal cord in vitro.
Magnuson DS; Dickenson AH
J Neurophysiol; 1991 Dec; 66(6):1941-50. PubMed ID: 1812227
[TBL] [Abstract][Full Text] [Related]
18. A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices.
Calabresi P; Siniscalchi A; Pisani A; Stefani A; Mercuri NB; Bernardi G
Neurology; 1996 Aug; 47(2):557-62. PubMed ID: 8757038
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical and behavioral aspects of lamotrigine.
Leach MJ; Baxter MG; Critchley MA
Epilepsia; 1991; 32 Suppl 2():S4-8. PubMed ID: 1685439
[TBL] [Abstract][Full Text] [Related]
20. Weak blockade of AMPA receptor-mediated depolarisations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepine.
Phillips I; Martin KF; Thompson KS; Heal DJ
Eur J Pharmacol; 1997 Oct; 337(2-3):189-95. PubMed ID: 9430413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
